Literature DB >> 3950417

Immunohistological studies with A1-3, a monoclonal antibody to activated human monocytes and macrophages.

W W Hancock, F R Rickles, V A Ewan, R C Atkins.   

Abstract

A wide variety of monoclonal antibodies (mAb) have now been produced which recognize cell surface antigens on human peripheral blood monocytes. However, few of these mAb demonstrate specificity for monocytes, and fewer still recognize antigens exclusively on monocytes activated by one or more stimuli and/or block specific monocyte functions. The mAb A1-3 binds to lipopolysaccharide (LPS)-stimulated monocytes but not to resting blood monocytes, and inhibits the procoagulant activity of these LPS-activated cells. By using this mAb, we examined the reactivity of monocytes/macrophages (MO) in a broad range of normal and inflammatory tissues by means of a sensitive, four-layer immunoperoxidase technique. Cells of the MO system, in addition to lymphocytes and dendritic cells resident in lymphoid tissues, liver, lung, and other organs, were nonreactive with the A1-3 mAb. In contrast, intense staining of inflammatory MO was found in biopsies from patients with renal allograft rejection, acute glomerulonephritis, or granulomatous diseases. This apparent restriction of A1-3 binding to inflammatory, "activated" MO suggests that A1-3 mAb will be useful for the analysis of MO "activation" in many pathologic processes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950417

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen.

Authors:  P Brandtzaeg; D B Jones; D J Flavell; M K Fagerhol
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

Review 2.  Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

Authors:  M Shoji; W W Hancock; K Abe; C Micko; K A Casper; R M Baine; J N Wilcox; I Danave; D L Dillehay; E Matthews; J Contrino; J H Morrissey; S Gordon; T S Edgington; B Kudryk; D L Kreutzer; F R Rickles
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  A monoclonal antibody (ER-HR3) against murine macrophages. I. Ontogeny, distribution and enzyme histochemical characterization of ER-HR3-positive cells.

Authors:  J P de Jong; J S Voerman; A J van der Sluijs-Gelling; R Willemsen; R E Ploemacher
Journal:  Cell Tissue Res       Date:  1994-03       Impact factor: 5.249

4.  Human macrophage maturation and heterogeneity: restricted expression of late differentiation antigens in situ.

Authors:  R Andreesen; S Gadd; U Costabel; H G Leser; V Speth; B Cesnik; R C Atkins
Journal:  Cell Tissue Res       Date:  1988-08       Impact factor: 5.249

5.  Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis.

Authors:  M A Cassatella; G Berton; C Agostini; R Zambello; L Trentin; A Cipriani; G Semenzato
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

6.  Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macrophages.

Authors:  A E Koch; J C Burrows; A Skoutelis; R Marder; P H Domer; B Anderson; S J Leibovich
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.